Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer
暂无分享,去创建一个
[1] M. Roach. Commentary on a multi-institutional analysis of external beam radiotherapy for T1-T2 prostate cancer: "love the one you're with" and "do the right thing". , 2003, International journal of radiation oncology, biology, physics.
[2] A. Evans,et al. Clinical predictors of gleason score upgrading , 2007, Cancer.
[3] G. Brix,et al. Methods for quantitative assessment of tissue microcirculation using dynamic contrast-enhanced MR imaging , 1997, Der Radiologe.
[4] E. Rostrup,et al. Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.
[5] A Heerschap,et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors , 2001, Journal of magnetic resonance imaging : JMRI.
[6] Stacey A. Kenfield,et al. Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Chinyere N. Onyebuchi,et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy , 2004, Cancer.
[8] R. Jain,et al. Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.
[9] A. Moore. Tumor behavior in isolated perfused organs: In vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment , 1967 .
[10] W. J. Lorenz,et al. Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.
[11] A. Partin,et al. Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer. , 2001, Reviews in urology.
[12] H. Huisman,et al. Accurate estimation of pharmacokinetic contrast‐enhanced dynamic MRI parameters of the prostate , 2001, Journal of magnetic resonance imaging : JMRI.
[13] D. Beyersdorff,et al. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] P. Carroll,et al. Validity of prostate‐specific antigen as a tumour marker in men with prostate cancer managed by watchful‐waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging , 2007, BJU international.
[15] Neil Fleshner,et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. , 2002, The Journal of urology.
[16] Bernd Hamm,et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.
[17] H. Schlemmer,et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004, European Radiology.
[18] F. Rojo,et al. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. , 2006, Histology and histopathology.
[19] Matthias Taupitz,et al. Evaluation of Normal Prostate Tissue, Chronic Prostatitis, and Prostate Cancer by Quantitative Perfusion Analysis Using a Dynamic Contrast-Enhanced Inversion-Prepared Dual-Contrast Gradient Echo Sequence , 2008, Investigative radiology.
[20] Masoom A Haider,et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[21] D. Dearnaley,et al. Dynamic contrast-enhanced MRI for prostate cancer localization. , 2009, The British journal of radiology.
[22] S. Katz,et al. The Importance of Correct Norms in Blood Volume Measurement , 2007, The American journal of the medical sciences.
[23] D. Beyersdorff,et al. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer]. , 2009, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[24] G Brix,et al. Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[25] Robert E Lenkinski,et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.
[26] M. Zelefsky. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer , 2005 .
[27] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[28] D. Beyersdorff,et al. Simultaneous Quantification of Perfusion and Permeability in the Prostate Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging with an Inversion-Prepared Dual-Contrast Sequence , 2009, Annals of Biomedical Engineering.
[29] Janet E. Husband,et al. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma , 1995 .
[30] M. Brawer,et al. Topography of neovascularity in human prostate carcinoma , 1995, Cancer.
[31] H. Schlemmer,et al. Can preoperative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004 .
[32] E. Heath,et al. Angiogenesis inhibitors in the treatment of prostate cancer , 2010, Journal of hematology & oncology.
[33] S. Kozerke,et al. Accelerated parallel imaging by transform coding data compression with k-t SENSE , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.
[34] Ting-Yim Lee,et al. An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: II. Experimental Validation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] Namkug Kim,et al. Functional MR imaging of prostate cancer. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.
[36] Peter L Choyke,et al. Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.
[37] P. Carroll,et al. Imaging for recurrent prostate cancer. , 2000, Radiologic clinics of North America.
[38] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[39] Napoleone Ferrara,et al. Angiogenesis as a therapeutic target , 2005, Nature.
[40] Thomas Hambrock,et al. Feasibility of 3T Dynamic Contrast-Enhanced Magnetic Resonance-Guided Biopsy in Localizing Local Recurrence of Prostate Cancer After External Beam Radiation Therapy , 2010, Investigative radiology.
[41] Matthias Taupitz,et al. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. , 2009, Radiology.
[42] I. Floriani,et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. , 2008, AJR. American journal of roentgenology.
[43] W. Catalona,et al. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.
[44] J F Gross,et al. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.
[45] Donald E Bailey,et al. Active surveillance for early‐stage prostate cancer , 2008, Cancer.
[46] G. Wright,et al. Rapid high‐resolution T1 mapping by variable flip angles: Accurate and precise measurements in the presence of radiofrequency field inhomogeneity , 2006, Magnetic resonance in medicine.
[47] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[48] L R Schad,et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.
[49] B. Vojnovic,et al. Evaluation of the anti‐vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI , 2002, NMR in biomedicine.
[50] M. Knopp,et al. Dynamic contrast‐enhanced MRI using Gd‐DTPA: Interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors , 2001, Magnetic resonance in medicine.
[51] D P Dearnaley,et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. , 2001, Radiology.
[52] L Axel,et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. , 1989, Radiology.
[53] Robert C. Frazier,et al. Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy , 1999, Cancer.
[54] A. Neugut,et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. , 1999, Urology.
[55] Olivier Rouvière,et al. Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy , 2009, European Radiology.
[56] M. Knopp,et al. [Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography]. , 1997, Der Radiologe.
[57] P S Tofts,et al. Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.
[58] J. Blasko,et al. Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer. , 2000, Seminars in urologic oncology.
[59] P. Walsh. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. , 2005, The Journal of urology.
[60] Greg Schaefer,et al. Angiogenesis in Prostate Cancer: Biology and Therapeutic Opportunities , 2004, Cancer and Metastasis Reviews.
[61] J. Kurhanewicz,et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.
[62] F. Schick,et al. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in Human Blood Plasma at 0.2, 1.5, and 3 Tesla , 2006, Investigative radiology.
[63] Thomas Hambrock,et al. Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility , 2008, Investigative Radiology.
[64] A. Jackson,et al. Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[65] J. Heverhagen,et al. Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI. , 2006, Magnetic resonance imaging.
[66] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[67] J. L. Stephenson,et al. Theory of the measurement of blood flow by the dilution of an indicator. , 1948, The Bulletin of mathematical biophysics.
[68] W Blumenfeld,et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.
[69] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.
[70] Adam S. Kibel,et al. Screening and Prostate-Cancer Mortality in a Randomized European Study , 2009 .
[71] Caroline Reinhold,et al. Artifacts and pitfalls in MR imaging of the pelvis , 2007, Journal of magnetic resonance imaging : JMRI.
[72] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[73] P. Asbach,et al. Pharmakokinetische MRT der Prostata: Parameter zur Unterscheidung von Low-grade- und High-grade-Prostatakarzinomen , 2009 .
[74] P. Choyke,et al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies , 2008, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.
[75] Y. Ville,et al. Placental perfusion and permeability: simultaneous assessment with dual-echo contrast-enhanced MR imaging in mice. , 2006, Radiology.
[76] Thorsten Schlomm,et al. Prognostic value of microvessel density in prostate cancer: a tissue microarray study , 2010, World Journal of Urology.
[77] John E Tomaszewski,et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era , 2002, Cancer.
[78] Tristan Barrett,et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. , 2007, AJR. American journal of roentgenology.
[79] N. Rofsky,et al. Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement , 2006, European Radiology.
[80] J. Heitman,et al. Microbial genetics: Love the one you're with , 2009, Nature.
[81] J. Pouliot,et al. Efficacy of external beam radiotherapy compared to permanent prostate implant in treating low risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and PSA , 2004 .
[82] Wolfhard Semmler,et al. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI , 2004, European Radiology.
[83] J. Concato,et al. Molecular markers and mortality in prostate cancer , 2007, BJU international.
[84] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[85] D. Buckley,et al. Precision in measurements of perfusion and microvascular permeability with T1‐weighted dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[86] J. Battermann,et al. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. , 2010, International journal of radiation oncology, biology, physics.
[87] P. Gabriele,et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging , 2009, European Radiology.
[88] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[89] A. Partin,et al. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in gleason sum 5 to 7 adenocarcinoma of the prostate , 1997, Cancer.
[90] Liang Cheng,et al. Prostate needle biopsies , 2004, Cancer.
[91] Evis Sala,et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. , 2006, Radiology.
[92] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[93] J. Chapelon,et al. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI , 2009, European Radiology.
[94] Stuart J. Russell,et al. Do the right thing , 1991 .
[95] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[96] William J Catalona,et al. Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.
[97] D. Beyersdorff,et al. Implementation of a rapid inversion-prepared dual-contrast gradient echo sequence for quantitative dynamic contrast-enhanced magnetic resonance imaging of the human prostate. , 2005, Magnetic resonance imaging.
[98] Thomas Hambrock,et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.
[99] H. Hricak,et al. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.
[100] D. Beyersdorff,et al. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. , 2005, AJR. American journal of roentgenology.
[101] H. Sandler,et al. A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer. , 2003, International journal of radiation oncology, biology, physics.
[102] A. Hanlon,et al. Patterns and fate of PSA bouncing following 3D-CRT. , 2001, International journal of radiation oncology, biology, physics.
[103] M. Brawer,et al. Comparison of microscopic vascularity in benign and malignant prostate tissue. , 1993, Human pathology.
[104] Martin O Leach,et al. Reference tissue quantification of DCE-MRI data without a contrast agent calibration , 2007, Physics in medicine and biology.
[105] Olivier Rouvière,et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings. , 2004, Urology.
[106] J. Heiken,et al. Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. , 1993, Radiology.